|
Anti-Green Fluorescent Protein Antibodies
Applications
Western Blot
Immunocytochemistry
Immunohistochemistry
Specificity
Vertebrates
Subtype
Chicken Polyclonal
Immunogen
His-tagged green fluorescent protein of the bioluminescent hydrozoan jellyfish (Aequorea Victoria).
Technical Summary
Drs. Tomasiewicz, Wood, & Flaherty have created a polyclonal anti- green fluorescent...
Published: 9/26/2024
Contributor(s): Henry Tomasiewicz, John Wood, Denise Flaherty
|
|
SARS-CoV-2 Neutralizing Human Monoclonal Antibodies
Application
Monoclonal antibodies to SARS-CoV2 for use in COVID-19 diagnostics and therapeutics.
Key Benefits
Demonstrably neutralizing, important for therapeutic mAbs.
Most bind both RBG and stalk portion of spike protein, useful in case SARS-CoV2 strains develop variation in RBD.
Market Summary
Coronavirus (COVID-19) is an infectious...
Published: 10/17/2024
Contributor(s): Jens Wrammert, Carl Davis, Mehul Suthar, Robert Kauffman
|
|
BG505 SOSIP Vaccine Elicited Neutralizing Monoclonal Antibodies for HIV
Application
ELISA
Western Blot
Immunohistochemistry
Specficity
HIV-1 BG505 Env protein (clone name: YRK01, YRK02).
Subtype
Monoclonal antibody.
Immunogen
HIV-1 BG505 SOSIP Env trimer.
Technical Summary
HIV-1 envelope glycoprotein (Env) is a membrane protein complex involved in receptor recognition and viral fusion with CD4+ T cells...
Published: 10/28/2024
Contributor(s): Cynthia Derdeyn, Tysheena Charles
|
|
Galectin-9 Directed CAR T-cells for Overcoming Resistance to Chemotherapy in Hematological Malignancies
Application
Anti-human Galectin-9-directed chimeric antigen receptor (CAR) T-cells for treatment of hematological malignancies (B-ALL, T-ALL, and DLBCL) in normal, overweight, and obese patients.
Key Benefits
Can be used as a stand-alone or in-combination product to treat patients with hematological malignancies, particularly overweight and obese...
Published: 9/26/2024
Contributor(s): Curtis Henry, Miyoung (Mi-Young) Lee, Sunil Raikar, Jamie Hamilton, Anthony Ross
|
|
Trimeric Immunogen for HIV-1 Vaccination
Application
Trimeric gp120 immunogen that induces broadly cross-reactive V1V2-antibodies for HIV-1 vaccine.
Key Benefits
Possible oral administration.
Broadly cross-reactive against HIV-1 panel.
Promotes antibody responses as both a primary immunogen and boosting immunogen.
Market Summary
Antiretroviral therapy (ART) has dramatically prolonged...
Published: 11/20/2024
Contributor(s): Rama Rao Amara, Andrew Jones, Raghavan Varadarajan, Sannula Kesavardhana
|
|
Antibody Therapy for Varicella Zoster Virus
Application
Human monoclonal antibodies for the treatment of varicella zoster virus (VZV).
Key Benefits
Human monoclonal antibodies can limit the spread of VZV.
gH-specific antibodies are complement-independent.
Market Summary
Varicella Zoster Virus (VZV) causes varicella, more commonly known as chickenpox. Once the illness resolves, the virus...
Published: 11/20/2024
Contributor(s): Rafi Ahmed, Nicole Sullivan
|
|
Antibodies for Zika and Dengue Viruses
Applications
ELISA
Western Blot
Immunohistochemistry
Specificity
Human monoclonal
Technical Summary
Zika Virus (ZIKV) is a mosquito borne filovirus responsible for a 2016-2017 epidemic in North and South America. ZIKV nonstructural protein 1 (NS1) is a pathogenicity factor implicated in virus replication, host interaction and immune invasion....
Published: 7/30/2024
Contributor(s): Jens Wrammert, Mark Mulligan
|
|
Glycoprotein Tetramer for Identifying Antigen-specific B Cells
Application
Ectodomain of viral glycoprotein tetramers detects antigen-specific memory B Cells.
Key Benefits
Viral glycoprotein tetramers detect antigen-specific memory B cells in the peripheral blood and tissues.
Hepatitis C virus E2 protein triggers immune response, which may yield an effective vaccine against hepatitis C virus.
Market Summary
Hepatitis...
Published: 10/28/2024
Contributor(s): Arash Grakoui, Joseph Marcotrigiano
|
|
Promising Antibodies Target Virus Glycoprotein for Vaccination and Therapy
ApplicationAntibodies that bind and neutralize Ebola virus glycoprotein (GP) for use in vaccination or treatment of Ebola virus disease.Key BenefitsHigher binding affinity for Ebola virus GP than closest competitor.Can be used prophylactically or for treatment of Ebola virus disease.Market SummaryThe Ebola virus is an RNA virus with a membrane composed...
Published: 11/20/2024
Contributor(s): Rafi Ahmed, Carl Davis, Erica Ollmann Saphire
|
|
Specialized Cell Culturing Media for Enhanced Antibody Secretion and Plasma Cell Survival
Application
Cell culture media that promotes the survival of human plasma cells and enables immunoglobin (Ig) secretion from such plasma cells.
Key Benefits
Facilitates the isolation of antibody-secreting cells (ASCs) found in blood after antigen exposure, which can be used to identify an active antigen or pathogen causing illness.
Composed of...
Published: 7/30/2024
Contributor(s): Frances Eun-Hyung Lee, Ignacio (Inaki) Sanz, Doan Nguyen
|
